Patents by Inventor Laura Grosmaire

Laura Grosmaire has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • B-cell reduction using CD37-specific and CD20-specific binding molecules
    Publication number: 20070059306
    Abstract: The present invention generally provides methods for B-cell reduction in an individual using CD37-specific binding molecules. In particular, the invention provides methods for B-cell reduction using CD37-specific binding molecules alone, or a combination of CD37-specific binding molecules and CD20-specific binding molecules, in some instances a synergistic combination. The invention further provides materials and methods for treatment of diseases involving aberrant B-cell activity. In addition, the invention provides humanized CD37-specific binding molecules.
    Type: Application
    Filed: July 25, 2006
    Publication date: March 15, 2007
    Applicant: TRUBION PHARMACEUTICALS, INC.
    Inventors: Laura Grosmaire, Martha Hayden-Ledbetter, Jeffrey Ledbetter, Peter Thompson, Sandy Simon, William Brady
  • Compositions and methods for regulating lymphocyte activation
    Publication number: 20050261478
    Abstract: The present invention relates to regulation of lymphocyte activation. In particular, it relates to compositions and methods for regulating lymphocyte activation by selectively binding multiple cell surface antigens expressed by the same lymphocyte.
    Type: Application
    Filed: May 12, 2005
    Publication date: November 24, 2005
    Applicant: XCYTE Therapies, Inc.
    Inventors: Jeffrey Ledbetter, Martha Hayden Ledbetter, William Brady, Laura Grosmaire, Che-Leung Law, Raj Dua